Literature DB >> 30109163

Can Overuse of Kambô Cause Psychosis?

Renitha Roy1, Aparna Baranwal2, Eduardo D Espiridion3.   

Abstract

Kambô is an emerging ritual, which involves the application of the toxin produced by Phyllomedusa bicolor to a freshly burnt area to heal chronic diseases of the mind and body. Due to the widespread use of kambô, more cases of symptomatic health conditions are being discovered. In this case study, we report a patient with psychosis potentially due to the kambô ritual.

Entities:  

Keywords:  giant leaf frog toxin; kambô; neurochemical effects of toxin; phyllomedusa bicolor; shaman ritual; toxin-induced psychosis

Year:  2018        PMID: 30109163      PMCID: PMC6084690          DOI: 10.7759/cureus.2770

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


Introduction

Kambô is an emerging ritual, which involves the application of a toxin produced by a giant leaf frog, Phyllomedusa bicolor, to a freshly burnt skin area. This is being used to heal the chronic diseases of the mind and body. Due to the widespread use of kambô, more cases of symptomatic health conditions are being observed. In this case report, we report a patient who presented with new-onset psychotic symptoms, potentially due to the kambô ritual.

Case presentation

The patient is a 33-year-old Caucasian female, who was brought to the local emergency room by the police. The police were repeatedly called by the patient about rapes and shootings in her community. On the day she was brought to the hospital, the patient called the police under a fake name and complained that her husband was raping another individual. She was making nonsensical comments, including being ritualistically haunted by her father and sister. The patient was found to be unmarried and lived alone but was adamant about being married to a celebrity. She had no significant psychiatric history prior to this incident. After acknowledging that she was a certified shaman and practices healing through the utilization of the kambô ritual, she claimed that she uses the kambô toxin to alleviate her chronic pain. Her frequency of performing the ritual changed from once per month to up to nine times per month. She presented with characteristics of paranoia, anxiety, bizarre delusions, labile mood, and panic attacks. On physical examination, scars were noted on the patient’s legs from the burns and administration of the toxin. She subsequently had an unremarkable extensive medical workup. As part of her treatment plan, the patient was started on risperidone and she gradually improved after nine days in the hospital psychiatry unit.

Discussion

Phyllomedusa bicolor is a giant leaf frog that secretes toxins that potentially contain peptides, such as phyllokinin, phyllocaerulein, phyllomedusin, sauvagine, deltorphins, dermorphins, and adrenoregulin. This particular venom is used in a ritual of applying the toxins to a freshly inflicted burn on the body. The rituals are meant to purify the human body. However, there have been case reports of toxic hepatitis, syndrome of inappropriate antidiuretic hormone secretion (SIADH), and even death [1-3]. The toxin is found to have rapid effects of tachycardia, vomiting, and incontinence, which have led to euphoria and sedation [4]. Many components of the toxin have been discovered to have neurochemical effects. Deltorphin is a full selective agonist for the delta opioid receptors in the central nervous system. It has shown an analgesic effect in mice through the morphine (mu) and ketocyclazocine (kappa) opioid receptors [5]. Moreover, dermorphin has been shown to have a high potency and selectivity to the mu opioid receptors but has weak anti-nociceptive properties [6]. Another constituent, sauvagine, is associated with behavioral effects in mice. Sauvagine has effects on the adrenal cortex and corticotrophin-releasing factor (CRF). Data has shown that patients with post-traumatic stress disorder (PTSD) with secondary psychosis had increased levels of CRF, but in the control group with PTSD and no psychosis, CRF levels were within normal limits [7-8]. The patient had multiple doses of the kambô toxin leading to her hospital admission, which potentially had increased her CRF and may have caused her psychotic symptoms. With the various neuropeptides in the kambô toxin, which have known and unknown effects and interactions, any combinations of these compounds could have led to her psychotic status.

Conclusions

This is a patient who presented with significant disorganized behaviors and eccentric delusions without any known psychiatric issues. The only significant information pertaining to her was an increased use of the kambô toxin and her symptoms responded to antipsychotics. Based on the various components of the toxin, there can be a correlation between her psychosis and the overuse of kambô. Even with a recent increase in reported health impacts, there is still uncertainty on the complex toxic effects of the kambô toxin. Since these rituals have been increasing worldwide, such clinical presentations may increase as well.
  8 in total

1.  Frog secretions and hunting magic in the upper Amazon: identification of a peptide that interacts with an adenosine receptor.

Authors:  J W Daly; J Caceres; R W Moni; F Gusovsky; M Moos; K B Seamon; K Milton; C W Myers
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

Review 2.  Role of corticotropin releasing factor in anxiety disorders: a translational research perspective.

Authors:  Victoria B Risbrough; Murray B Stein
Journal:  Horm Behav       Date:  2006-07-25       Impact factor: 3.587

3.  Synthesis and pharmacology of halogenated δ-opioid-selective [d-Ala(2)]deltorphin II peptide analogues.

Authors:  Robyn Pescatore; Gina F Marrone; Seth Sedberry; Daniel Vinton; Netanel Finkelstein; Yitzchak E Katlowitz; Gavril W Pasternak; Krista R Wilson; Susruta Majumdar
Journal:  ACS Chem Neurosci       Date:  2015-04-14       Impact factor: 4.418

4.  Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects.

Authors:  Frederic J Sautter; Garth Bissette; Justin Wiley; Gina Manguno-Mire; Benjamin Schoenbachler; Leann Myers; Janet E Johnson; Arleen Cerbone; Dolores Malaspina
Journal:  Biol Psychiatry       Date:  2003-12-15       Impact factor: 13.382

5.  The Biological Effects of Kambo: Is There a Relationship Between its Administration and Sudden Death?

Authors:  Isabella Aquila; Santo Gratteri; Matteo A Sacco; Vittorio Fineschi; Simona Magi; Pasqualina Castaldo; Graziella Viscomi; Salvatore Amoroso; Pietrantonio Ricci
Journal:  J Forensic Sci       Date:  2017-09-08       Impact factor: 1.832

6.  The syndrome of inappropriate antidiuretic hormone secretion after giant leaf frog (Phyllomedusa bicolor) venom exposure.

Authors:  Vid Leban; Gordana Kozelj; Miran Brvar
Journal:  Toxicon       Date:  2016-07-12       Impact factor: 3.033

7.  Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo).

Authors:  Mark F Bird; Maria Camilla Cerlesi; Mark Brown; Davide Malfacini; Vanessa Vezzi; Paola Molinari; Laura Micheli; Lorenzo Di Cesare Mannelli; Carla Ghelardini; Remo Guerrini; Girolamo Calò; David G Lambert
Journal:  PLoS One       Date:  2016-06-07       Impact factor: 3.240

8.  Toxic hepatitis caused by the excretions of the Phyllomedusa bicolor frog - a case report.

Authors:  Joanna Pogorzelska; Tadeusz W Łapiński
Journal:  Clin Exp Hepatol       Date:  2017-01-19
  8 in total
  5 in total

Review 1.  KAMBÔ: an Amazonian enigma.

Authors:  Vidal Haddad Junior; Itamar Alves Martins
Journal:  J Venom Res       Date:  2020-05-26

2.  Acute and subacute psychoactive effects of Kambô, the secretion of the Amazonian Giant Maki Frog (Phyllomedusa bicolor): retrospective reports.

Authors:  Timo Torsten Schmidt; Simon Reiche; Caroline L C Hage; Felix Bermpohl; Tomislav Majić
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

3.  Connected to the spirit of the frog: An Internet-based survey on Kambô, the secretion of the Amazonian Giant Maki Frog (Phyllomedusa bicolor): Motivations for use, settings and subjective experiences.

Authors:  Tomislav Majić; Meike Sauter; Felix Bermpohl; Timo T Schmidt
Journal:  J Psychopharmacol       Date:  2021-03-04       Impact factor: 4.153

Review 4.  Kambo: Natural drug or potential toxic agent? A literature review of acute poisoning cases.

Authors:  M A Sacco; A Zibetti; C F Bonetta; C Scalise; L Abenavoli; F Guarna; S Gratteri; P Ricci; I Aquila
Journal:  Toxicol Rep       Date:  2022-04-15

5.  Kambô-Induced Systemic Inflammatory Response: A Case Report of Acute Disease Progression of Cholangiocarcinoma.

Authors:  Shira Peleg Hasson; Eliya Shachar; Rivka Kessner; Shulim Shpigel; Ido Wolf
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.